Nucleos(T)ide Analogue Treatment Has a More Pronounced Impact on Immune Repertoires of CHB Patients Compared to HCC Patients
The results suggest that NAs therapy could influence the overall T cell and B cell repertoires diversity in CHB patients but has minimal impact on HCC patients, indicating a significant difference in the potential to restore antiviral immunity between CHB and HCC patients by NAs treatment.
Authors
- Anqi Zheng (ORCID: https://orcid.org/0000-0003-2976-5819)
- Guojun Shen
- Mingxing Gong (ORCID: https://orcid.org/0000-0002-6506-8706)
- Xueying Li (ORCID: https://orcid.org/0000-0003-1307-9187)
- Zhanhui Wang (ORCID: https://orcid.org/0000-0001-9022-6545)
- Baolin Liao
Institutions
- Jiujiang First People's Hospital (CN)
- Nanfang Hospital (CN)
- ShenZhen People’s Hospital (CN)
- Guangzhou First People's Hospital (CN)
- Guangzhou Eighth People's Hospital (CN)
- Southern Medical University (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Journal of Inflammation Research
- Published
- 2024-09-01
- DOI
- https://doi.org/10.2147/jir.s471675
- Citations
- 1
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.39
Funders
- Guangzhou Municipal Science and Technology Bureau